Saudi Arabia Human Insulin market is anticipated to grow at a rate of s steady CAGR for the forecast period, 2023-2027. An increase in the number of patients suffering from diabetics and the high-end investments for research and development activities for drug discovery are the key driving factors for the Saudi Arabia Human Insulin market for the next five years.

Increasing Diabetes Prevalence Supports Market Growth

Saudi Arabia ranks second highest in the Middle East and seventh in the world by the World Health Organization (WHO). Diabetes is growing at a rapid rate, and the symptoms of diabetes are noticeable due to the changing disease patterns in the country. Diabetes mellitus adversely impacts an individual's health and leads to high morbidity, mortality, and vascular complications along with the poor quality of life and general health.

Insulin is used to treat diabetes, but still, many people are suffering from it and need quality treatment services. Market players are indulging in the research and development activities to devise effective ways to use insulin to treat diabetic patients and minimize the occurrence of side effects of taking insulin dosage. 

Supportive Healthcare Policies Spurs the Market Growth

The government is promoting the development of effective drugs and delivery systems to support diabetic patients in the country is influencing the demand of the Saudi Arabia Human Insulin market. Lack of physical activities and the adoption of an unhealthy lifestyle adversely affect the individual's health, which is also fueling the development of diabetes at an early stage. The technological advancements in the healthcare system and the surge in the number of patients who have diabetes are creating the demand for the development of effective diabetes drug treatment methods. Allocation of huge funds for the healthcare expenditure and the launch of programs aiming to educate people about diabetes, such as The National Executive Plan of Diabetes Control "2010-2021", The Saudi National Program of Education against Diabetes is expected to propel the market demand.

Rising Adoption of Wearable Devices Fuels Market Growth

The rise in consumer awareness about the advantages of preventive measures boosts the sales of wearable medical devices. Wearable devices for patients who have diabetes include using devices such as insulin pumps and continuous glucose monitoring systems, making the management of diabetes more efficient and easier. Wearable devices are in high demand among people who have type I diabetes.

Still, the growing advancements in technology have led to devices to treat type II diabetes. Continuous glucose monitoring allows the patients to monitor their glucose levels regularly, and the insulin pumps provide the required amount of insulin at the fixed time interval. The combination of the two technologies could lead to efficient management of diabetes with improved results. The rise in the disposable income of the consumers due to the efforts made by the leading authorities to generate other revenue sources than the oil and gas industry is expected to boost the demand for the Saudi Arabia Human Insulin market growth.


Click here to download the sample
Market Segmentation

The Saudi Arabia Human Insulin market is segmented on the basis of indication, route of administration, type, onset time, products, regional distribution, and company. Based on the indication, the market is divided into type I diabetes and type II diabetes. Based on the route of administration, the market is divided into subcutaneous, nasal, intravenous, transdermal, oral, and others. Based on the type, the market is divided into basal, bolus, pre-mixed, biosimilar, and traditional.


Based on the onset time, the market is divided into rapid-acting, short-acting, intermediate-acting, long-acting, ultra-long acting, pre-mixed, and inhaled. Based on the products, the market is divided into insulin pens, insulin pumps, infusion systems, injection. The Saudi Arabia Human Insulin market is studied in major regions, namely the North & Central region, Southern region, Western region, and Eastern region. 

Market Players

Novo Nordisk Saudi Arabia, Sanofi Saudi Arabia, Baxter International Saudi Arabia, B Braun Saudi Arabia, Eli Lilly, and Company Saudi Arabia, Pfizer Saudi Arabia, are among the major market players in Saudi Arabia platform that lead the market growth of Saudi Arabia Human Insulin market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Indication

·         Route of Administration

·         Type

·         Onset Time

·         Products

Regional scope

Northern & Central, Southern, Eastern, Western

Key companies profiled

Novo Nordisk Saudi Arabia, Sanofi Saudi Arabia, Baxter International Saudi Arabia, B Braun Saudi Arabia, Eli Lilly and Company Saudi Arabia, Pfizer Saudi Arabia

Customization scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Saudi Arabia Human Insulin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Saudi Arabia Human Insulin Market, By Indication:
    • Type I Diabetes
    • Type II Diabetes
  • Saudi Arabia Human Insulin Market, By Route of Administration:
    • Subcutaneous
    • Nasal
    • Intravenous
    • Transdermal
    • Oral
    • Others
  • Saudi Arabia Human Insulin Market, By Type:
    • Basal
    • Bolus
    • Pre-mixed
    • Biosimilar
    • Traditional
  • Saudi Arabia Human Insulin Market, By Onset Time:
    • Rapid Acting
    • Short-Acting
    • Intermediate Acting
    • Long Acting
    • Ultra-long Acting
    • Pre-Mixed
    • Inhaled
  • Saudi Arabia Human Insulin Market, By Products:
    • Insulin Pens
    • Insulin Pumps
    • Infusion System
    • Injection
  • Saudi Arabia Human Insulin Market, By Region:
    • Northern & Central
    • Southern
    • Eastern
    • Western

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Saudi Arabia Human Insulin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia Human Insulin Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Saudi Arabia Human Insulin Market

4.    Voice of Customer

5.    Executive Summary

6.    Saudi Arabia Human Insulin Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Indication (Type I Diabetes, Type II Diabetes)

6.2.2.     By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal,        

Oral and Others)

6.2.3.     By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)

6.2.4.     By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled)

6.2.5.     By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection)

6.2.6.     By Company (2021)

6.2.7.     By Region

6.3.  Product Market Map

7.    Northern & Central Saudi Arabia Human Insulin Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Indication

7.2.2.     By Route of Administration

7.2.3.     By Type

7.2.4.     By Onset Time

7.2.5.     By Products

8.    Southern Saudi Arabia Saudi Arabia Human Insulin Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Indication

8.2.2.     By Route of Administration

8.2.3.     By Type

8.2.4.     By Onset Time

8.2.5.     By Products

9.    Eastern Saudi Arabia Saudi Arabia Human Insulin Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Indication

9.2.2.     By Route of Administration

9.2.3.     By Type

9.2.4.     By Onset Time

9.2.5.     By Products

10.  Western Saudi Arabia Saudi Arabia Human Insulin Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Indication

10.2.2.  By Route of Administration

10.2.3.  By Type

10.2.4.  By Onset Time

10.2.5.  By Products

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  Saudi Arabia Economic Profile

15.  Competitive Landscape

15.1.              Competition Outlook

15.2.              Company Profiles

15.2.1.  Novo Nordisk Saudi Arabia

15.2.2.  Sanofi Saudi Arabia

15.2.3.  Baxter International Saudi Arabia

15.2.4.  B Braun Saudi Arabia

15.2.5.  Eli Lilly and Company Saudi Arabia

15.2.6.  Pfizer Saudi Arabia

16.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com